Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Richter Transformation: early-phase trial registry

2 of 2 indexed Richter Transformation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Richter Transformation: 2 US clinical trials tracked, 2 recruiting.

Richter Transformation is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Newave Pharmaceutical, running 1 of these trials.

Enrollment posture brief

Registry condition richter-transformation

OPEN 2 | RECR 100% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Richter Transformation (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Richter Transformation

Richter Transformation lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Richter Transformation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Richter Transformation is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Richter Transformation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

zamtocabtagene autoleucel (MB-CART2019.1) Biological
1 trials
LP-118 Drug
1 trials
Bendamustine Drug
1 trials
Fludarabine Drug
1 trials
Cyclophosphamide Drug
1 trials

US sites by state

Facility locations filed on Richter Transformation trials. A trial with sites in several states counts in each.

Ohio 2 trials
North Carolina 2 trials
Massachusetts 2 trials
Illinois 2 trials
Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oregon 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Richter Transformation page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Richter Transformation condition card totals 2 registered trials; most-linked intervention zamtocabtagene autoleucel (MB-CART2019.1); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.